By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem today said that it has entered into a supply and distribution deal with privately held Cancer Genetics (CGI) covering the use of Enzo Life Sciences' fluorescent dye labels for increasing signal intensity in labeling nucleic acids.

Under the non-exclusive agreement, Enzo Life Sciences will incorporate its labels into CGI's nucleic acid material that it and supplies to the research market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.